Second-time EIA publication of Rionlon Pharma's vitamin K2 project

On 26 Sept., the environmental impact assessment details of "vitamin K2 API preparation and relevant intermediates project", submitted by Rionlon (Tianjin) Pharmaceutical Co., Ltd. (Rionlon Pharma), were publicised for the second time. Project overvi...

Vitamins China E-News 202410

www.cnchemicals.com